We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.9B
AUM Growth
-$755M
Cap. Flow
-$1.47B
Cap. Flow %
-12.34%
Top 10 Hldgs %
33.73%
Holding
1,207
New
25
Increased
513
Reduced
317
Closed
41

Sector Composition

Rank Sector Weight
1 Real Estate 71.54%
2 Technology 3.97%
3 Industrials 3.48%
4 Financials 2.88%
5 Healthcare 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBC icon
1026
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
$9K ﹤0.01%
500
ENTA icon
1027
Enanta Pharmaceuticals
ENTA
$372M
$9K ﹤0.01%
105
INSM icon
1028
Insmed
INSM
$23.2B
$9K ﹤0.01%
423
INVA icon
1029
Innoviva
INVA
$1.58B
$9K ﹤0.01%
597
PBYI icon
1030
Puma Biotechnology
PBYI
$406M
$9K ﹤0.01%
207
RETA
1031
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$9K ﹤0.01%
110
SPPI
1032
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$9K ﹤0.01%
556
GBT
1033
DELISTED
Global Blood Therapeutics, Inc.
GBT
$9K ﹤0.01%
241
CTXS
1034
PUT
DELISTED
Citrix Systems Inc
CTXS
$9K ﹤0.01%
+1,192
New +$132K
ZGNX
1035
DELISTED
Zogenix, Inc.
ZGNX
$9K ﹤0.01%
189
ELP
1036
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$8K ﹤0.01%
4,000
FL
1037
DELISTED
Foot Locker
FL
$8K ﹤0.01%
152
SGMO
1038
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$8K ﹤0.01%
467
TXMD icon
1039
TherapeuticsMD
TXMD
$23.8M
$8K ﹤0.01%
24
GTHX
1040
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$8K ﹤0.01%
157
CLVS
1041
DELISTED
Clovis Oncology, Inc.
CLVS
$8K ﹤0.01%
271
AIMT
1042
DELISTED
Aimmune Therapeutics
AIMT
$8K ﹤0.01%
281
EDIT icon
1043
Editas Medicine
EDIT
$399M
$7K ﹤0.01%
233
LKFT
1044
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$7K ﹤0.01%
60
LW icon
1045
Lamb Weston
LW
$6.82B
$7K ﹤0.01%
100
-900
-90% -$61.8K
NTLA icon
1046
Intellia Therapeutics
NTLA
$1.5B
$7K ﹤0.01%
234
ITCI
1047
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7K ﹤0.01%
302
IMGN
1048
DELISTED
Immunogen Inc
IMGN
$7K ﹤0.01%
731
LMNX
1049
DELISTED
Luminex Corp
LMNX
$7K ﹤0.01%
243
BOLD
1050
DELISTED
Audentes Therapeutics, Inc
BOLD
$7K ﹤0.01%
165

Similar funds

Daiwa Securities Group's Q3 2018 Portfolio in Review

As of Q3 2018, Daiwa Securities Group held 1,207 positions worth $11.9B, down 5.9% from $12.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $1.47B in Q3 2018, closing 41 positions and reducing 317 holdings. Its most notable exit was SITE Centers, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 73% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Altaba Inc worth $4.33M.

  • Daiwa Securities Group's largest Q3 2018 buy was Altaba Inc: 63,550 shares worth $4.33M.
  • Daiwa Securities Group added most to Welltower in Q3 2018, an estimated $281M increase.
  • Daiwa Securities Group's biggest Q3 2018 reduction was Boston Properties, cutting an estimated $240M.
  • Daiwa Securities Group fully exited SITE Centers in Q3 2018, selling an estimated $128M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $11.9B portfolio in Q3 2018.
  • Daiwa Securities Group opened 25 new positions and closed 41 in Q3 2018.
  • Daiwa Securities Group's portfolio value fell 5.9% quarter-over-quarter to $11.9B.

Based on Daiwa Securities Group's 13F filing for Q3 2018, filed 1 Nov 2018.